Related Experiment Video

Updated: Jun 16, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Clinical benefits of tight glycaemic control: focus on the paediatric patient

Ingeborg van den Heuvel1, Dirk Vlasselaers

  • 1Department of Anaesthesiology and Intensive Care Medicine, University Hospital Muenster, Albert-Schweitzer-Strasse 33, 48149, Muenster, Germany. vandenhe@uni-muenster.de

Best Practice & Research. Clinical Anaesthesiology
|January 30, 2010
PubMed

Insights

Tight glycaemic control (TGC) in critically ill children may reduce inflammation and infections but increases hypoglycemia risk. Further multicenter trials are needed to confirm benefits and determine optimal blood glucose targets.

Area of Science:

  • Pediatric critical care medicine
  • Endocrinology
  • Clinical research

Background:

  • Hyperglycemia and glucose variability are common in critically ill children, linked to poorer outcomes.
  • The causal relationship between glucose control and outcomes requires investigation through randomized controlled trials (RCTs).

Purpose of the Study:

  • To evaluate the efficacy of tight glycaemic control (TGC) using insulin infusion in critically ill children.
  • To assess the impact of TGC on morbidity and mortality in this population.

Main Methods:

  • The study references a single-center RCT that demonstrated the feasibility of TGC.
  • This trial involved intensive insulin infusion to manage blood glucose levels.

Main Results:

  • TGC led to reduced inflammation, fewer secondary infections, shorter intensive care stays, and decreased need for hemodynamic support.
  • A significant increase in biochemical hypoglycemia was observed as a consequence of TGC.

Conclusions:

  • While TGC shows promise in critically ill children, long-term effects on development and optimal glucose targets require further investigation.
  • Multicenter prospective RCTs are essential before widespread implementation, with potential benefits from technological advancements in glucose monitoring.

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...